Andreessen Horowitz

Levels is a health and wellness company that focuses on metabolic fitness through a platform that tracks blood glucose levels in real-time. Founded in 2019, the company offers a wearable device that provides users with immediate feedback on their unique metabolism. This data enables individuals to understand how their bodies respond to various dietary and lifestyle choices, allowing them to optimize their nutrition and exercise routines to meet personal health goals. Operating as a remote-first organization, Levels aims to empower users to take control of their metabolic health.

Q Bio, founded in 2015 by Jeffrey Kaditz, Dr. Michael Snyder, and Dr. Garry Choy, operates a clinical digital twin platform aimed at assessing patients' medical histories to identify immediate and future health risks. Based in San Carlos, California, the company utilizes whole-body scans to create a digital twin of each patient's physical body, quantifying and digitizing health data. By leveraging simulated human physiology and machine learning, Q Bio's platform can predict potential health risks, enabling healthcare professionals to provide proactive treatment. The interdisciplinary team at Q Bio comprises experts in applied mathematics, computational physics, electrical engineering, genetics, and radiology, supported by prominent venture capital firms.

Pomelo Care is a leader in evidence-based maternity care, offering comprehensive support for women throughout preconception, pregnancy, birth, postpartum, and their infant’s first year. The company combines virtual, round-the-clock clinical care with in-person doula services to create a unique support model that effectively addresses medical, behavioral, and social factors influencing maternal and infant health. By leveraging data science and machine learning, Pomelo identifies and manages risks associated with pregnancy and postpartum care, aiming to enhance health outcomes while reducing unnecessary costs. The platform provides personalized care plans and resources to meet the specific needs of pregnant individuals and newborns, collaborating with employers as well as commercial and Medicaid health plans to promote accessible and high-quality care.

Hippocratic AI focuses on developing safety-oriented large language models specifically designed for non-diagnostic, patient-facing applications in healthcare. Unlike conventional models that are often trained on diverse internet data, which may include unreliable information, Hippocratic AI emphasizes the acquisition of evidence-based healthcare content through lawful channels. The company aims to enhance healthcare accessibility and outcomes by creating a platform that facilitates safe artificial health general intelligence. This innovation seeks to empower patients to manage their health more effectively from home, thereby improving overall health outcomes with minimal inconvenience.

Turquoise Health is a health tech company focused on simplifying healthcare administration to lower costs and reduce complexity. By leveraging data from hospital and payer machine-readable files, the company has created a marketplace that connects patients, providers, and payers. Its platform allows users to browse and compare prices for elective services offered by hospitals, as well as to compare insurance services. This functionality enables individuals to save money on elective treatments and helps healthcare organizations attract both cash-paying and insured patients. Turquoise Health aims to enhance transparency in healthcare pricing, ultimately benefiting all stakeholders involved.

Inductive Bio specializes in providing a machine learning platform that enhances the compound optimization process for drug development. The company focuses on addressing ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) challenges by building comprehensive datasets and machine learning models. This enables scientists to efficiently identify and refine small molecule compounds, transforming initial candidates into viable leads more rapidly and with improved properties. By streamlining the optimization process, Inductive Bio supports the development of new therapeutics, ultimately contributing to advancements in the pharmaceutical industry.

MedScout is a revenue acceleration platform tailored for medical device and diagnostic companies. It offers sales enablement software that integrates medical claims intelligence from both public and private payors, providing users with critical insights into market dynamics. The platform is designed to assist sales professionals and leaders by delivering data on patient demographics, procedure volumes, referral patterns, and payment information. This functionality allows clients to conduct thorough market analysis, develop effective strategies, and enhance sales execution, ultimately optimizing operational productivity and fostering growth in their respective territories.

Pomelo Care is a leader in evidence-based maternity care, offering comprehensive support for women throughout preconception, pregnancy, birth, postpartum, and their infant’s first year. The company combines virtual, round-the-clock clinical care with in-person doula services to create a unique support model that effectively addresses medical, behavioral, and social factors influencing maternal and infant health. By leveraging data science and machine learning, Pomelo identifies and manages risks associated with pregnancy and postpartum care, aiming to enhance health outcomes while reducing unnecessary costs. The platform provides personalized care plans and resources to meet the specific needs of pregnant individuals and newborns, collaborating with employers as well as commercial and Medicaid health plans to promote accessible and high-quality care.

Hippocratic AI focuses on developing safety-oriented large language models specifically designed for non-diagnostic, patient-facing applications in healthcare. Unlike conventional models that are often trained on diverse internet data, which may include unreliable information, Hippocratic AI emphasizes the acquisition of evidence-based healthcare content through lawful channels. The company aims to enhance healthcare accessibility and outcomes by creating a platform that facilitates safe artificial health general intelligence. This innovation seeks to empower patients to manage their health more effectively from home, thereby improving overall health outcomes with minimal inconvenience.

Memora Health Inc., founded in 2016 and based in San Francisco, California, develops an enterprise healthcare productivity platform aimed at automating outpatient communication and enhancing care delivery. The company partners with health systems, health plans, and digital health organizations to streamline clinical workflows, allowing clinicians to focus on their primary responsibilities while proactively engaging patients throughout their care journeys. Memora's platform digitizes high-touch processes, intelligently triaging patient-reported data to the relevant care team members and facilitating proactive, two-way communication between patients and providers. By transforming the way care is delivered, Memora Health seeks to make healthcare more actionable, accessible, and continuous.

Zus Health is a healthcare technology company founded in 2020 in Watertown, Massachusetts, by Jonathan Bush. The company develops a healthcare data platform aimed at accelerating digital health initiatives. Its platform uniquely integrates health and non-health data, offering a comprehensive view of patients while facilitating the sharing of clinical and non-clinical information across different applications. This approach empowers healthcare professionals to create customized digital technologies and services that are more affordable and accessible, addressing the common barriers in the healthcare sector. Zus Health is focused on fostering innovation among a new generation of healthcare builders, striving to enhance the overall health experience.

Marker Learning specializes in evaluations and support services for learning disabilities, utilizing a telepsychology platform to enhance accessibility for schools and families. The company offers diagnostic assessments for various learning disabilities, as well as individualized learning plans, tutoring, and coaching aimed at helping students and adults up to the age of 50 achieve their full potential. Marker Learning's licensed psychologists have received specialized training to ensure effective and personalized support for individuals facing learning challenges.

Firefly Health, Inc. is a Massachusetts-based company that develops an artificial intelligence-driven platform to connect patients with healthcare professionals. Founded in 2016, it focuses on providing primary healthcare services that emphasize accessibility and quality. The platform allows users to navigate their health while offering care for common conditions such as back pain, stomach flu, and women's health issues. Firefly Health utilizes a virtual-first approach, enabling patients to access live video appointments with primary care physicians without membership fees. This model facilitates continuous and intelligent care, empowering patients to make informed health choices and allowing clinicians to deliver consistent and proactive support.

Tomorrow Health is a technology-driven home healthcare company based in New York, New York, that operates an online marketplace for medical supplies and equipment. Founded in 2018, it provides a wide range of products, including wheelchairs, ventilators, prosthetics, and wound care items. The company connects patients, health plans, and home-based care suppliers to improve access to necessary medical equipment while simplifying the ordering and insurance processes. By matching patients with suppliers based on factors such as insurance coverage and service quality, Tomorrow Health aims to streamline logistics and enhance personalized support for families managing care at home. Through its innovative approach, the company seeks to eliminate paperwork and reduce delivery delays, ensuring patients receive the essential supplies they need.

Turquoise Health is a health tech company focused on simplifying healthcare administration to lower costs and reduce complexity. By leveraging data from hospital and payer machine-readable files, the company has created a marketplace that connects patients, providers, and payers. Its platform allows users to browse and compare prices for elective services offered by hospitals, as well as to compare insurance services. This functionality enables individuals to save money on elective treatments and helps healthcare organizations attract both cash-paying and insured patients. Turquoise Health aims to enhance transparency in healthcare pricing, ultimately benefiting all stakeholders involved.

Deepcell, Inc. is a biotechnology company based in Mountain View, California, that specializes in providing advanced diagnostic solutions through its innovative microfluidic imaging platform. Founded in 2015, the company focuses on delivering non-invasive tests with diagnostic-level accuracy, enabling researchers and clinicians to gain insights at the single-cell level. Deepcell's technology employs artificial intelligence to analyze and classify cells based on their morphological features, isolating viable cells for various applications in translational research, diagnostic testing, and therapeutics. By utilizing ordinary blood samples, Deepcell enhances the understanding of genetic health without the need for invasive procedures, thereby improving the diagnosis and treatment of diseases.

Memora Health Inc., founded in 2016 and based in San Francisco, California, develops an enterprise healthcare productivity platform aimed at automating outpatient communication and enhancing care delivery. The company partners with health systems, health plans, and digital health organizations to streamline clinical workflows, allowing clinicians to focus on their primary responsibilities while proactively engaging patients throughout their care journeys. Memora's platform digitizes high-touch processes, intelligently triaging patient-reported data to the relevant care team members and facilitating proactive, two-way communication between patients and providers. By transforming the way care is delivered, Memora Health seeks to make healthcare more actionable, accessible, and continuous.

Topography Health is a clinical trials platform designed to facilitate private practice physicians' participation in medical research. The company aids medical practices in understanding their patient demographics and recommends suitable studies that are likely to be effective and well-received. Additionally, Topography assists in patient recruitment and the hiring and management of research staff. By enabling local clinical trials, Topography Health provides patients with various health conditions access to personalized clinical trial opportunities, ultimately advancing medical research and overcoming barriers that physicians face in entering this field.

Sprinter Health is an on-demand mobile health company that sends full-time nurses and phlebotomists (“Sprinters”) into the home.

Pomelo Care is a leader in evidence-based maternity care, offering comprehensive support for women throughout preconception, pregnancy, birth, postpartum, and their infant’s first year. The company combines virtual, round-the-clock clinical care with in-person doula services to create a unique support model that effectively addresses medical, behavioral, and social factors influencing maternal and infant health. By leveraging data science and machine learning, Pomelo identifies and manages risks associated with pregnancy and postpartum care, aiming to enhance health outcomes while reducing unnecessary costs. The platform provides personalized care plans and resources to meet the specific needs of pregnant individuals and newborns, collaborating with employers as well as commercial and Medicaid health plans to promote accessible and high-quality care.

Turquoise Health is a health tech company focused on simplifying healthcare administration to lower costs and reduce complexity. By leveraging data from hospital and payer machine-readable files, the company has created a marketplace that connects patients, providers, and payers. Its platform allows users to browse and compare prices for elective services offered by hospitals, as well as to compare insurance services. This functionality enables individuals to save money on elective treatments and helps healthcare organizations attract both cash-paying and insured patients. Turquoise Health aims to enhance transparency in healthcare pricing, ultimately benefiting all stakeholders involved.

Zus Health is a healthcare technology company founded in 2020 in Watertown, Massachusetts, by Jonathan Bush. The company develops a healthcare data platform aimed at accelerating digital health initiatives. Its platform uniquely integrates health and non-health data, offering a comprehensive view of patients while facilitating the sharing of clinical and non-clinical information across different applications. This approach empowers healthcare professionals to create customized digital technologies and services that are more affordable and accessible, addressing the common barriers in the healthcare sector. Zus Health is focused on fostering innovation among a new generation of healthcare builders, striving to enhance the overall health experience.

Born from the founders’ recognition that their diverse but complementary skills and experiences would enable them to successfully address challenges that others had not, the company set about solving a vexing problem: how to bring true proteomics to the world in a way that accelerates therapeutic development, dramatically improves medical diagnostics, and makes personalized and predictive medicine a reality. The extraordinary team at Nautilus represents a wide spectrum of disciplines and expertise, including protein chemists, chip designers, molecular biologists, data scientists, material scientists, biophysicists, optical engineers, microfluidics engineers, bioinformaticists, software engineers, and more. Nautilus is positioned to revolutionize proteomics, transform the way drugs are developed, and significantly improve the way human health is managed.

Memora Health Inc., founded in 2016 and based in San Francisco, California, develops an enterprise healthcare productivity platform aimed at automating outpatient communication and enhancing care delivery. The company partners with health systems, health plans, and digital health organizations to streamline clinical workflows, allowing clinicians to focus on their primary responsibilities while proactively engaging patients throughout their care journeys. Memora's platform digitizes high-touch processes, intelligently triaging patient-reported data to the relevant care team members and facilitating proactive, two-way communication between patients and providers. By transforming the way care is delivered, Memora Health seeks to make healthcare more actionable, accessible, and continuous.

Tomorrow Health is a technology-driven home healthcare company based in New York, New York, that operates an online marketplace for medical supplies and equipment. Founded in 2018, it provides a wide range of products, including wheelchairs, ventilators, prosthetics, and wound care items. The company connects patients, health plans, and home-based care suppliers to improve access to necessary medical equipment while simplifying the ordering and insurance processes. By matching patients with suppliers based on factors such as insurance coverage and service quality, Tomorrow Health aims to streamline logistics and enhance personalized support for families managing care at home. Through its innovative approach, the company seeks to eliminate paperwork and reduce delivery delays, ensuring patients receive the essential supplies they need.

Firefly Health, Inc. is a Massachusetts-based company that develops an artificial intelligence-driven platform to connect patients with healthcare professionals. Founded in 2016, it focuses on providing primary healthcare services that emphasize accessibility and quality. The platform allows users to navigate their health while offering care for common conditions such as back pain, stomach flu, and women's health issues. Firefly Health utilizes a virtual-first approach, enabling patients to access live video appointments with primary care physicians without membership fees. This model facilitates continuous and intelligent care, empowering patients to make informed health choices and allowing clinicians to deliver consistent and proactive support.

Komodo Health Inc. is a healthcare technology company that specializes in providing real-time healthcare intelligence and transparency through its innovative platform. Founded in 2014 and based in New York, with an additional office in San Francisco, the company offers a suite of software solutions, including its Healthcare Map, which tracks patient outcomes across the healthcare system. The platform utilizes advanced data science techniques and artificial intelligence to deliver insights that empower various stakeholders in the healthcare sector, including life science companies, payers, and providers. Key products such as Aperture, Pulse, and Serenity facilitate the analysis of complex healthcare connections, alert users to influence disease burden positively, and explore patient cohorts for deeper insights. By enabling a more cost-effective and value-driven healthcare system, Komodo Health aims to set a new standard for real-world data and analytics in the industry.

Deepcell, Inc. is a biotechnology company based in Mountain View, California, that specializes in providing advanced diagnostic solutions through its innovative microfluidic imaging platform. Founded in 2015, the company focuses on delivering non-invasive tests with diagnostic-level accuracy, enabling researchers and clinicians to gain insights at the single-cell level. Deepcell's technology employs artificial intelligence to analyze and classify cells based on their morphological features, isolating viable cells for various applications in translational research, diagnostic testing, and therapeutics. By utilizing ordinary blood samples, Deepcell enhances the understanding of genetic health without the need for invasive procedures, thereby improving the diagnosis and treatment of diseases.

Levels is a health and wellness company that focuses on metabolic fitness through a platform that tracks blood glucose levels in real-time. Founded in 2019, the company offers a wearable device that provides users with immediate feedback on their unique metabolism. This data enables individuals to understand how their bodies respond to various dietary and lifestyle choices, allowing them to optimize their nutrition and exercise routines to meet personal health goals. Operating as a remote-first organization, Levels aims to empower users to take control of their metabolic health.

PatientPing, Inc. is a health technology company that has established a national care coordination network designed to connect healthcare providers with real-time notifications whenever patients receive care. The network encompasses a diverse group of healthcare personnel, including physicians, nurses, case managers, and care coordinators across various settings such as hospitals, emergency departments, and skilled nursing facilities. PatientPing offers technology solutions tailored to Accountable Care Organizations (ACOs) and other healthcare providers, facilitating improved collaboration and information sharing. One of its key tools, Spotlights, leverages real-time data to identify utilization and performance trends in patient care. Founded in 2013 and headquartered in Boston, Massachusetts, PatientPing operates as a subsidiary of SVB Leerink Holdings LLC and maintains a strategic partnership with MedAllies, Inc. By fostering connections among care teams, PatientPing aims to enhance the quality and efficiency of healthcare delivery, ultimately leading to better patient outcomes.

Born from the founders’ recognition that their diverse but complementary skills and experiences would enable them to successfully address challenges that others had not, the company set about solving a vexing problem: how to bring true proteomics to the world in a way that accelerates therapeutic development, dramatically improves medical diagnostics, and makes personalized and predictive medicine a reality. The extraordinary team at Nautilus represents a wide spectrum of disciplines and expertise, including protein chemists, chip designers, molecular biologists, data scientists, material scientists, biophysicists, optical engineers, microfluidics engineers, bioinformaticists, software engineers, and more. Nautilus is positioned to revolutionize proteomics, transform the way drugs are developed, and significantly improve the way human health is managed.

Topography Health is a clinical trials platform designed to facilitate private practice physicians' participation in medical research. The company aids medical practices in understanding their patient demographics and recommends suitable studies that are likely to be effective and well-received. Additionally, Topography assists in patient recruitment and the hiring and management of research staff. By enabling local clinical trials, Topography Health provides patients with various health conditions access to personalized clinical trial opportunities, ultimately advancing medical research and overcoming barriers that physicians face in entering this field.

Tomorrow Health is a technology-driven home healthcare company based in New York, New York, that operates an online marketplace for medical supplies and equipment. Founded in 2018, it provides a wide range of products, including wheelchairs, ventilators, prosthetics, and wound care items. The company connects patients, health plans, and home-based care suppliers to improve access to necessary medical equipment while simplifying the ordering and insurance processes. By matching patients with suppliers based on factors such as insurance coverage and service quality, Tomorrow Health aims to streamline logistics and enhance personalized support for families managing care at home. Through its innovative approach, the company seeks to eliminate paperwork and reduce delivery delays, ensuring patients receive the essential supplies they need.

Q Bio, founded in 2015 by Jeffrey Kaditz, Dr. Michael Snyder, and Dr. Garry Choy, operates a clinical digital twin platform aimed at assessing patients' medical histories to identify immediate and future health risks. Based in San Carlos, California, the company utilizes whole-body scans to create a digital twin of each patient's physical body, quantifying and digitizing health data. By leveraging simulated human physiology and machine learning, Q Bio's platform can predict potential health risks, enabling healthcare professionals to provide proactive treatment. The interdisciplinary team at Q Bio comprises experts in applied mathematics, computational physics, electrical engineering, genetics, and radiology, supported by prominent venture capital firms.

Komodo Health Inc. is a healthcare technology company that specializes in providing real-time healthcare intelligence and transparency through its innovative platform. Founded in 2014 and based in New York, with an additional office in San Francisco, the company offers a suite of software solutions, including its Healthcare Map, which tracks patient outcomes across the healthcare system. The platform utilizes advanced data science techniques and artificial intelligence to deliver insights that empower various stakeholders in the healthcare sector, including life science companies, payers, and providers. Key products such as Aperture, Pulse, and Serenity facilitate the analysis of complex healthcare connections, alert users to influence disease burden positively, and explore patient cohorts for deeper insights. By enabling a more cost-effective and value-driven healthcare system, Komodo Health aims to set a new standard for real-world data and analytics in the industry.

Omada Health, Inc. is a digital healthcare company that creates and implements online programs aimed at managing chronic conditions. Founded in 2011 and headquartered in San Francisco, with an additional office in Atlanta, Omada Health focuses on helping employers and health plans identify individuals at risk for preventable chronic diseases such as prediabetes, diabetes, hypertension, and heart disease. The company offers personalized programs that adapt to the unique needs of participants, incorporating professional health coaching, connected health devices, and real-time data to foster sustainable lifestyle changes. Omada Health is recognized as the largest provider of the National Diabetes Prevention Program, delivering clinically effective solutions that empower individuals to take charge of their health and achieve their wellness goals.

Q Bio, founded in 2015 by Jeffrey Kaditz, Dr. Michael Snyder, and Dr. Garry Choy, operates a clinical digital twin platform aimed at assessing patients' medical histories to identify immediate and future health risks. Based in San Carlos, California, the company utilizes whole-body scans to create a digital twin of each patient's physical body, quantifying and digitizing health data. By leveraging simulated human physiology and machine learning, Q Bio's platform can predict potential health risks, enabling healthcare professionals to provide proactive treatment. The interdisciplinary team at Q Bio comprises experts in applied mathematics, computational physics, electrical engineering, genetics, and radiology, supported by prominent venture capital firms.

Deepcell, Inc. is a biotechnology company based in Mountain View, California, that specializes in providing advanced diagnostic solutions through its innovative microfluidic imaging platform. Founded in 2015, the company focuses on delivering non-invasive tests with diagnostic-level accuracy, enabling researchers and clinicians to gain insights at the single-cell level. Deepcell's technology employs artificial intelligence to analyze and classify cells based on their morphological features, isolating viable cells for various applications in translational research, diagnostic testing, and therapeutics. By utilizing ordinary blood samples, Deepcell enhances the understanding of genetic health without the need for invasive procedures, thereby improving the diagnosis and treatment of diseases.

Medisas is a team of experienced and passionate clinicians, engineers, designers reinventing hospital software.

PatientPing, Inc. is a health technology company that has established a national care coordination network designed to connect healthcare providers with real-time notifications whenever patients receive care. The network encompasses a diverse group of healthcare personnel, including physicians, nurses, case managers, and care coordinators across various settings such as hospitals, emergency departments, and skilled nursing facilities. PatientPing offers technology solutions tailored to Accountable Care Organizations (ACOs) and other healthcare providers, facilitating improved collaboration and information sharing. One of its key tools, Spotlights, leverages real-time data to identify utilization and performance trends in patient care. Founded in 2013 and headquartered in Boston, Massachusetts, PatientPing operates as a subsidiary of SVB Leerink Holdings LLC and maintains a strategic partnership with MedAllies, Inc. By fostering connections among care teams, PatientPing aims to enhance the quality and efficiency of healthcare delivery, ultimately leading to better patient outcomes.

Cardiogram, Inc., established in 2015 and based in San Francisco, California, specializes in developing wearable devices and applications to monitor and analyze heart health. The company's technology enables users to track heart rate measurements, providing insights into how their heart responds during workouts and how various factors such as stress, diet, and exercise affect their resting heart rate. The application supports cardio-tracking for devices like the Apple Watch and Android Wear, allowing users to detect heartbeats, monitor sleep, and maintain fitness. By enabling users to visualize and share their heart rate data, Cardiogram aims to help prevent serious heart-related issues such as strokes.

Q Bio, founded in 2015 by Jeffrey Kaditz, Dr. Michael Snyder, and Dr. Garry Choy, operates a clinical digital twin platform aimed at assessing patients' medical histories to identify immediate and future health risks. Based in San Carlos, California, the company utilizes whole-body scans to create a digital twin of each patient's physical body, quantifying and digitizing health data. By leveraging simulated human physiology and machine learning, Q Bio's platform can predict potential health risks, enabling healthcare professionals to provide proactive treatment. The interdisciplinary team at Q Bio comprises experts in applied mathematics, computational physics, electrical engineering, genetics, and radiology, supported by prominent venture capital firms.

Omada Health, Inc. is a digital healthcare company that creates and implements online programs aimed at managing chronic conditions. Founded in 2011 and headquartered in San Francisco, with an additional office in Atlanta, Omada Health focuses on helping employers and health plans identify individuals at risk for preventable chronic diseases such as prediabetes, diabetes, hypertension, and heart disease. The company offers personalized programs that adapt to the unique needs of participants, incorporating professional health coaching, connected health devices, and real-time data to foster sustainable lifestyle changes. Omada Health is recognized as the largest provider of the National Diabetes Prevention Program, delivering clinically effective solutions that empower individuals to take charge of their health and achieve their wellness goals.

Human API is a digital health data network that allows consumers to easily access and share their health information from various sources, including hospitals, electronic medical records, pharmacies, labs, and wearable devices. Founded in 2013 and based in San Mateo, California, the company connects to data from 90% of US hospitals and over 300 wellness applications. The platform employs a machine learning-powered data pipeline to standardize health data, making it more accessible and actionable for medical researchers and scientists. Importantly, it empowers consumers to maintain control over their personal health data, determining which companies can access their information. This streamlined approach addresses the challenges of fragmented health data sources, facilitating efficient data sharing and utilization in the healthcare ecosystem.

uBiome, Inc. was a microbial genomics company based in San Francisco, California, specializing in sequencing-based clinical microbiome tests. Founded in 2012, it offered a range of products including SmartGut, a test for identifying harmful and beneficial microorganisms linked to specific infections; SmartJane, a women’s health screening for conditions like HPV and STIs; Explorer kits for researchers and citizen scientists; and SmartFlu, a clinical test for respiratory infections. The company's goal was to enhance understanding of the human microbiome and its implications for health. However, uBiome faced financial difficulties and filed for Chapter 11 bankruptcy in September 2019, which was later converted to Chapter 7 on October 11, 2019, marking the end of its operations.

Omada Health, Inc. is a digital healthcare company that creates and implements online programs aimed at managing chronic conditions. Founded in 2011 and headquartered in San Francisco, with an additional office in Atlanta, Omada Health focuses on helping employers and health plans identify individuals at risk for preventable chronic diseases such as prediabetes, diabetes, hypertension, and heart disease. The company offers personalized programs that adapt to the unique needs of participants, incorporating professional health coaching, connected health devices, and real-time data to foster sustainable lifestyle changes. Omada Health is recognized as the largest provider of the National Diabetes Prevention Program, delivering clinically effective solutions that empower individuals to take charge of their health and achieve their wellness goals.

Jawbone is a company specializing in personal technology, focusing on creating comfortable, usable, and aesthetically pleasing devices. Its flagship product, the Jawbone Bluetooth headset, is renowned for its exceptional sound quality, enhanced by NoiseAssassin technology, which was initially developed for military applications to eliminate background noise and ensure clear communication. In addition to audio products, Jawbone has ventured into the health and fitness sector by developing biometric wearable devices. These devices are designed to monitor daily activities, sleep patterns, and eating habits, helping users lead healthier lives. The UP Platform, an open API associated with these fitness trackers, allows users to track their fitness levels and make informed health choices.

Human API is a digital health data network that allows consumers to easily access and share their health information from various sources, including hospitals, electronic medical records, pharmacies, labs, and wearable devices. Founded in 2013 and based in San Mateo, California, the company connects to data from 90% of US hospitals and over 300 wellness applications. The platform employs a machine learning-powered data pipeline to standardize health data, making it more accessible and actionable for medical researchers and scientists. Importantly, it empowers consumers to maintain control over their personal health data, determining which companies can access their information. This streamlined approach addresses the challenges of fragmented health data sources, facilitating efficient data sharing and utilization in the healthcare ecosystem.

Jawbone is a company specializing in personal technology, focusing on creating comfortable, usable, and aesthetically pleasing devices. Its flagship product, the Jawbone Bluetooth headset, is renowned for its exceptional sound quality, enhanced by NoiseAssassin technology, which was initially developed for military applications to eliminate background noise and ensure clear communication. In addition to audio products, Jawbone has ventured into the health and fitness sector by developing biometric wearable devices. These devices are designed to monitor daily activities, sleep patterns, and eating habits, helping users lead healthier lives. The UP Platform, an open API associated with these fitness trackers, allows users to track their fitness levels and make informed health choices.